MedTrace Logo

The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses

NCT03525847 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-08-25

No results posted yet for this study

Summary

A prospective study designed to show the superiority of contrast guided echoendoscopy versus conventional echoendoscopy

Conditions

  • Endoscopic Ultrasonography

Interventions

DIAGNOSTIC_TEST

Endosonography

Puncture of the pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control. Passage in the same pancreatic mass of first using standard FNA method then contrast enhanced FNA method or vice versa according to the randomization

Sponsors & Collaborators

  • Professor Dr. Seicean Andrada

    lead OTHER

Principal Investigators

  • Seicean Andrada · Regional Institute of Gastroenterology and Hepatology "Octavian Fodor"Cluj-Napoca

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
86 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2019-01-01
Completion
2020-01-01

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03525847 on ClinicalTrials.gov